PAMU
GILD icon

Pictet Asset Management (UK)’s Gilead Sciences GILD Stock Holding History

Pictet Asset Management (UK)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-722,800
Closed -$47M – 1147
2019
Q4 		$47M Buy
+722,800
New +$47.1M 0.08% 277

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Pictet Asset Management (UK)'s GILD Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Gilead Sciences (GILD) stake by 7.9% in Q2 2021, selling an estimated $27.6M and leaving 4,802,990 shares worth $331M. The position accounts for 0.36% of the portfolio, ranked #78.

Pictet Asset Management (UK) first reported a position in GILD in Q2 2013 and has held it in 33 quarters since. The position peaked at $337M in Q1 2021. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Pictet Asset Management (UK) held 4,802,990 shares of Gilead Sciences worth $331M as of Q2 2021.
  • Pictet Asset Management (UK) sold 413,477 Gilead Sciences shares in Q2 2021, an estimated $27.6M.
  • Gilead Sciences made up 0.36% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #78 holding.
  • Pictet Asset Management (UK) first reported a position in Gilead Sciences in Q2 2013 and has held it in 33 quarters since.
  • Pictet Asset Management (UK)'s Gilead Sciences position peaked at $337M in Q1 2021.
  • 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.